Sanofi
SNYNF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $95 | $99 | $126 | $115 |
| - Cash | $9 | $15 | $8 | $7 |
| + Debt | $22 | $22 | $21 | $18 |
| Enterprise Value | $108 | $106 | $139 | $125 |
| Revenue | $13 | $11 | $11 | $11 |
| % Growth | 22.7% | 1.2% | -7.1% | – |
| Gross Profit | $10 | $8 | $8 | $8 |
| % Margin | 74.1% | 72.1% | 72.8% | 68.7% |
| EBITDA | $4 | $2 | $3 | $1 |
| % Margin | 32% | 17.6% | 26.1% | 4.9% |
| Net Income | $3 | $4 | $2 | $1 |
| % Margin | 21.3% | 36.7% | 17.7% | 6% |
| EPS Diluted | 2.27 | 3.19 | 1.52 | 0.4 |
| % Growth | -28.8% | 109.9% | 280% | – |
| Operating Cash Flow | – | $0 | $2 | $0 |
| Capital Expenditures | – | $0 | $0 | $0 |
| Free Cash Flow | – | $0 | $2 | $0 |